Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)

被引:42
|
作者
Kenny, GE
Cartwright, FD
机构
关键词
D O I
10.1128/AAC.40.4.1048
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibilities of mycoplasmas to a new quinolone, trovafloxacin (CP-99,219), were compared,vith those to sparfloxacin and ofloxacin, Mycoplasma pneumoniae was as susceptible to trovafloxacin (MIC = 0.25 mu g/ml) as to sparfloxacin and fourfold less susceptible to ofloxacin. Mycoplasma hominis was highly susceptible to trovafloxacin (MIC = 0.06 mu g/ml) and sparfloxacin (MIC = 0.03 mu g/ml) and less susceptible to ofloxacin (MIC = 0.5 mu g/ml). Ureaplasma urealyticum was most susceptible to trovafloxacin, with susceptibilities ranging from 0.06 to 0.5 mu g/ml compared with 0.25 to 1.0 mu g of sparfloxacin per ml and 1 to 4 mu g of ofloxacin per ml .
引用
收藏
页码:1048 / 1049
页数:2
相关论文
共 50 条
  • [41] EXPERIMENTALLY-INDUCED SEPTIC ARTHRITIS IN CHIMPANZEES INFECTED WITH MYCOPLASMA-HOMINIS, MYCOPLASMA-PNEUMONIAE, AND UREAPLASMA-UREALYTICUM
    BARILE, MF
    KAPATAISZOUMBOS, K
    SNOY, P
    GRABOWSKI, MW
    SNELLER, M
    MILLER, L
    CHANDLER, DKF
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) : 694 - 703
  • [42] Standardized Methods and Quality Control Limits for Agar and Broth Microdilution Susceptibility Testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum
    Waites, Ken B.
    Duffy, Lynn B.
    Bebear, Cecile M.
    Matlow, Anne
    Talkington, Deborah F.
    Kenny, George E.
    Totten, Patricia A.
    Bade, Donald J.
    Zheng, Xiaotian
    Davidson, Maureen K.
    Shortridge, Virginia D.
    Watts, Jeffrey L.
    Brown, Steven D.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) : 3542 - 3547
  • [43] IN-VITRO ACTIVITY OF THE NEW FLUOROQUINOLONE CP-99,219
    NEU, HC
    CHIN, NX
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) : 2615 - 2622
  • [44] In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens
    Crokaert, F
    Aoun, M
    Duchateau, V
    Grenier, P
    Vandermies, A
    Klastersky, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 696 - 698
  • [45] Azithromycin treatment for nongonococcal urethritis negative for Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum
    Maeda, Shin-ichi
    Yasuda, Mitsuru
    Ito, Shin
    Seike, Kensaku
    Ito, Shin-ichi
    Deguchi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (02) : 215 - 216
  • [46] DETECTION OF MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM IN PATIENTS WITH LEUKOSPERMIA
    SCHMIDT, U
    PFUTZNER, H
    HARTMANN, M
    ARCHIV FUR EXPERIMENTELLE VETERINARMEDIZIN, 1989, 43 (05): : 801 - 808
  • [47] The resistance of Ureaplasma urealyticum and Mycoplasma hominis to antimicrobial agents in Latvian population
    Tkacheva, A.
    Lavrinovica, E.
    Jacobsone, I.
    Bondareva, V.
    Skrupskis, A.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 : 47 - 48
  • [48] Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi'an, China
    Zeng, X. -Y.
    Xin, N.
    Tong, X. -N.
    Wang, J. -Y.
    Liu, Z. -W.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (12) : 1941 - 1947
  • [49] MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM IN NEONATES WITH SUSPECTED INFECTION
    VALENCIA, GB
    BANZON, F
    CUMMINGS, M
    MCCORMACK, WM
    GLASS, L
    HAMMERSCHLAG, MR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (07) : 571 - 573
  • [50] DETERMINATION OF YIELDS OF UREAPLASMA UREAPLASMA-UREALYTICUM AND MYCOPLASMA HOMINIS IN BROMOTHYMOL BLUE BROTH
    ROBERTSON, JA
    STEMKE, GW
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1978, 241 (02): : 272 - 273